Mubadala Healthcare Expands Plan for Imperial College London Diabetes Centre

Mubadala Healthcare announced plans to expand the existing services of Imperial College London Diabetes Center (ICLDC) through the establishment of a second facility in Al Ain.

Accordingly, this new Center will provide world-class medical care for local residents in Al Ain and the surrounding region from the middle of next year.

The Center is founded on the four pillars of treatment, training, public health and research, and provides the highest level of specialized and comprehensive patient care – from first diagnosis to the management of all the complications associated with diabetes. The expansion of services into Al Ain will be an extension of the same model of care.

The International Diabetes Federation has estimated that 18.7% of the UAE population is living with Diabetes and according to the Centre’s figures, an average of 15% of their patients reside outside Abu Dhabi in Al Ain.

“It is testament to the excellent work carried out at the Centre over the past four years that we are now able to replicate the same model of care for patients living outside the capital. I am delighted to build upon our partnership with Imperial College London with a second facility and improve access to world-class healthcare in the region,” said Suhail Mahmood Al Ansari, Associate Director of Mubadala Healthcare and Chairman of ICLDC.

Share/Save